Latest & greatest articles for metformin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on metformin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on metformin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for metformin

101. Use of metformin in obese pregnant women without diabetes mellitus: a systematic review and meta-analysis of two randomized controlled trials

Use of metformin in obese pregnant women without diabetes mellitus: a systematic review and meta-analysis of two randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

102. The effects of metformin on insulin resistance in obese children and adolescents: a systematic review and meta-analysis of randomized controlled trials

The effects of metformin on insulin resistance in obese children and adolescents: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

103. Metformin for the prevention of colorectal cancer: review of systematic reviews

Metformin for the prevention of colorectal cancer: review of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

104. The effect of metformin or other anti-diabetes drugs on bone health in diabetic patients: a systematic review and meta-analysis

The effect of metformin or other anti-diabetes drugs on bone health in diabetic patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

105. The effect of metformin on weight and other metabolic parameters and outcomes in obese non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials

The effect of metformin on weight and other metabolic parameters and outcomes in obese non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2018 PROSPERO

106. The effect of metformin on exercise capacity: a systematic review and meta-analysis

The effect of metformin on exercise capacity: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

107. The efficacy and safety of metformin for patients with type 1 diabetes: a systematic review and meta-analysis

The efficacy and safety of metformin for patients with type 1 diabetes: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2018 PROSPERO

108. Metformin monotherapy for adults with type 2 diabetes mellitus [Cochrane protocol]

Metformin monotherapy for adults with type 2 diabetes mellitus [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

109. DPP-4 inhibitors with metformin as initial treatment versus high dose or low dose of metformin in type 2 diabetes patients: a systematic review and meta-analysis

DPP-4 inhibitors with metformin as initial treatment versus high dose or low dose of metformin in type 2 diabetes patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2018 PROSPERO

110. Effect of Metformin on Cerebral Ischemic Stroke: a Systematic Review and Meta-Analysis of Animal Studies

Effect of Metformin on Cerebral Ischemic Stroke: a Systematic Review and Meta-Analysis of Animal Studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

111. Conservative management of stage 1 endometrial adenocarcinoma with weight loss +/- metformin +/- levonorgestrel intrauterine device: a systematic review

Conservative management of stage 1 endometrial adenocarcinoma with weight loss +/- metformin +/- levonorgestrel intrauterine device: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

112. Natural Killer cells and T helper cells function and cardiovascular risk in type 2 diabetic patients on Metformin: A protocol for a Systematic Review.

Natural Killer cells and T helper cells function and cardiovascular risk in type 2 diabetic patients on Metformin: A protocol for a Systematic Review. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

113. Metformin and health outcomes: an umbrella review of systematic reviews with meta-analyses

Metformin and health outcomes: an umbrella review of systematic reviews with meta-analyses Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

114. Evaluation of the use of metformin in non-diabetic obese pregnant women: a systematic review and meta-analysis

Evaluation of the use of metformin in non-diabetic obese pregnant women: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

115. The association of premorbid metformin use on mortality and organ dysfunction in sepsis: a systematic review and meta-analysis

The association of premorbid metformin use on mortality and organ dysfunction in sepsis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

116. The association between hypoglycemia and metformin

The association between hypoglycemia and metformin Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect

2018 PROSPERO

117. Cost effectiveness of sodium-glucose cotransporter 2 (sglt-2) inhibitors and glucagon-like peptide 1 (glp-1) agonists in treatment of type 2 diabetes patients who failed with metformin monotherapy: a systematic review and meta-analysis of economic evaluat

Cost effectiveness of sodium-glucose cotransporter 2 (sglt-2) inhibitors and glucagon-like peptide 1 (glp-1) agonists in treatment of type 2 diabetes patients who failed with metformin monotherapy: a systematic review and meta-analysis of economic evaluat Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content

2018 PROSPERO

118. The efficacy and safety of sodium glucose co-transporter inhibitors as add-ons to pioglitazone with or without metformin in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

The efficacy and safety of sodium glucose co-transporter inhibitors as add-ons to pioglitazone with or without metformin in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any

2018 PROSPERO

119. In metabolic syndrome patients, is sitagliptin and metformin compared to metformin alone improve metabolic syndrome measuresa systematicreview and meta-analysis

In metabolic syndrome patients, is sitagliptin and metformin compared to metformin alone improve metabolic syndrome measuresa systematicreview and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2018 PROSPERO

120. Vitamin B12 (cobalamin) status among adult patients with type 2 diabetes prescribed metformin: a systematic review and meta-analysis

Vitamin B12 (cobalamin) status among adult patients with type 2 diabetes prescribed metformin: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO